HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 2 analysts with an average price target of $41.63. This is a potential upside of $15.07 (56.74%) from yesterday's end of day stock price of $26.56.

Harmony Biosciences Holdings's activity chart (see below) currently has 49 price targets and 37 ratings on display. The stock rating distribution of HRMY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.52% with an average time for these price targets to be met of 90.91 days.

Highest price target for HRMY is $70, Lowest price target is $36, average price target is $54.6.

Most recent stock forecast was given by DAVID HOANG from DEUTSCHE BANK on 25-Sep-2025. First documented stock forecast 10-Sep-2020.

Split History since 2000:

12/5/00 3 for 1

Currently out of the existing stock ratings of HRMY, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$36

$8.49 (30.86%)

$55

13 days ago
(25-Sep-2025)

0/4 (0%)

$8.96 (33.14%)

Buy

$48

$20.72 (75.95%)

$44

4 months 24 days ago
(14-May-2025)

8/15 (53.33%)

$13.77 (40.23%)

118

Buy

$70

$42.49 (154.45%)

$70

6 months ago
(08-Apr-2025)

0/7 (0%)

$41.87 (148.84%)

Buy

$61

$33.72 (123.61%)

$59

8 months 26 days ago
(12-Jan-2025)

1/6 (16.67%)

$24.55 (67.35%)

219

Buy

$58

$30.49 (110.83%)

$49

11 months 8 days ago
(30-Oct-2024)

0/7 (0%)

$24.2 (71.60%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 90.91 days on average for the stock forecasts to be realized with a an average price target met ratio 46.52

Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

AMI FADIA

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia has 7 price targets and 4 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

David Amsellem with highest potential upside - $42.72

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Corinne Jenkins with lowest potential downside - $0.72

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?